CJC-1295 NO-DAC
- In stock, ready to ship
- Backordered, shipping soon
CJC-1295 NO-DAC
Precision GHRH Analogue Advanced Tool for Growth Hormone & Metabolic Research
Overview
CJC-1295 is a synthetic Growth Hormone-Releasing Hormone (GHRH) analogue engineered to stimulate endogenous growth hormone (GH) secretion. By binding with high affinity to GHRH receptors in the pituitary, it serves as a critical agent for investigating endocrine signaling and the GH/IGF-1 axis. It is available in two distinct research formats: with DAC (Drug Affinity Complex) for extended half-life and without DAC for studies requiring a pulsatile release.
Primary Research Objectives
-
Endocrine Modulation: Evaluating the stimulation of the pituitary to increase GH secretion.
-
Metabolic Signaling: Studying the compound's impact on recovery pathways and systemic metabolism.
-
Kinetic Analysis: Comparing the effects of sustained (DAC) versus pulsatile (Non-DAC) GH release profiles.
-
Preclinical Recovery: Investigating regulatory mechanisms within the IGF-1 axis for tissue repair research.
Why Researchers Choose CJC-1295
-
Versatile Design: Offers both short-term and extended-release options to suit diverse study protocols.
-
Targeted Affinity: Specifically engineered to interact with GHRH receptors with high precision.
-
Exceptional Stability: Provided in a lyophilized form to ensure long-term potency and ease of storage.
-
Verified Quality: Every lot is batch-tested for ≥98% purity to guarantee experimental reproducibility.
Strictly for Research: This product is intended solely for laboratory and scientific investigation. Not for human or veterinary consumption, therapeutic use, or diagnostic procedures.